Shares of Digirad Corp. (NASDAQ:DRAD) saw unusually-high trading volume on Thursday . Approximately 91,440 shares changed hands during mid-day trading, an increase of 80% from the previous session’s volume of 50,870 shares.The stock last traded at $5.94 and had previously closed at $6.01.

DRAD has been the topic of a number of recent analyst reports. Sidoti initiated coverage on shares of Digirad Corp. in a report on Wednesday, May 25th. They issued a “buy” rating and a $8.00 price target on the stock. Zacks Investment Research upgraded shares of Digirad Corp. from a “hold” rating to a “buy” rating and set a $6.00 price target on the stock in a report on Tuesday, May 3rd. Finally, B. Riley restated a “buy” rating and issued a $7.00 price target on shares of Digirad Corp. in a report on Sunday, May 1st.

The company’s 50-day moving average is $5.45 and its 200 day moving average is $5.21. The company has a market capitalization of $111.00 million and a PE ratio of 3.48.

Digirad Corp. (NASDAQ:DRAD) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09. On average, equities research analysts anticipate that Digirad Corp. will post $0.32 earnings per share for the current fiscal year.

In other Digirad Corp. news, insider Virgil Lott sold 23,333 shares of the business’s stock in a transaction dated Wednesday, June 8th. The shares were sold at an average price of $5.25, for a total transaction of $122,498.25. Following the sale, the insider now directly owns 78,242 shares in the company, valued at $410,770.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey E. Eberwein purchased 6,700 shares of the business’s stock in a transaction on Friday, May 27th. The shares were acquired at an average price of $5.00 per share, for a total transaction of $33,500.00. Following the completion of the purchase, the director now directly owns 100,000 shares of the company’s stock, valued at $500,000. The disclosure for this purchase can be found here.

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.